Table 5 The clinical characteristics of caesarean scar pregnancy
n = 338 | % | |
|---|---|---|
Age (y) | ||
< 20 | 0 | 0.00 |
20–29 | 81 | 23.96 |
30–39 | 227 | 67.16 |
≥ 40 | 30 | 8.88 |
Mean ± SD | 32.90 ± 4.80 | |
Gestational age (weeks) | ||
< 6 | 74 | 23.57 |
6 ~ 8 | 167 | 53.18 |
≥ 8 | 73 | 23.25 |
Unclear gestational age | 24 | |
Mean ± SD | 6.67 ± 1.82 | |
Gestation history | ||
Childbearing history | 338 | 100.00 |
Abortion history | 271 | 80.18 |
Ectopic pregnancy history | 22 | 6.51 |
Pelvic disease history | 3 | 0.89 |
Pelvic surgery history (except caesarean delivery) | 28 | 8.28 |
Caesarean delivery history | ||
1 | 246 | 72.78 |
2 | 85 | 25.15 |
3 | 7 | 2.07 |
Assisted reproduction history | 3 | 0.89 |
Birth control history | 8 | 2.37 |
Intrauterine contraceptive device | 2 | 0.59 |
Oral contraceptive | 5 | 0.15 |
Ligation operation | 1 | 0.30 |
Clinical manifestations | ||
Amenorrhea | 333 | 98.52 |
Abdominal pain | 87 | 25.74 |
Vaginal bleeding | 229 | 67.76 |
Syncope | 0 | 0.00 |
Shock | 0 | 0.00 |
Signs | ||
Adnexal mass | 6 | 1.78 |
Adnexal tenderness | 4 | 1.18 |
Cervical pain when lifting | 9 | 2.66 |
Uterine enlargement | 158 | 46.75 |
Aspirating blood during culdocentesis | 0 | 0.00 |
HCG (U/L) | ||
HCG < 20,000 | 100 | 39.06 |
20,000 ≤ HCG < 100,000 | 110 | 42.97 |
HCG ≥ 100,000 | 46 | 17.97 |
Unclear HCG | 112 | |
Progesterone (nmol/L) | ||
P < 60 | 134 | 56.07 |
60 ≤ P < 120 | 93 | 38.91 |
P ≥ 120 | 12 | 5.02 |
Unclear P | 129 | |
Treatment methods | ||
Suction curettage | 136 | 40.23 |
Suction curettage + uterine artery embolization | 126 | 37.28 |
Other surgical treatment methods | 54 | 15.98 |
Conservative treatment methods | 6 | 1.78 |
Refused treatments | 16 | 4.73 |